- $2.17bn
- $2.55bn
- $4.55bn
- 68
- 81
- 16
- 56
Annual income statement for RXO, fiscal year end - December 31st, USD millions except per share, conversion factor applied.
2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | 2024 December 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | PROSPECTUS/A | PROSPECTUS/A | 10-K | 10-K | 10-K |
| Standards: | USG | USG | USG | USG | USG |
| Status: | Final | Final | Final | Final | Final |
| Revenue | |||||
| Total Revenue | 3,357 | 4,689 | 4,796 | 3,927 | 4,550 |
| Cost of Revenue | |||||
| Gross Profit | 615 | 816 | 946 | 725 | 783 |
| Selling / General / Administrative Expenses | |||||
| Depreciation and Amortization | |||||
| Unusual Expense / Income | |||||
| Other Operating Expenses | |||||
| Total Operating Expenses | 3,297 | 4,497 | 4,673 | 3,888 | 4,822 |
| Operating Profit | 60 | 192 | 123 | 39 | -272 |
| Total Net Non Operating Interest Income / Expense | |||||
| Total Net Non Operating Interest Income / Expense | |||||
| Other Net Non Operating Costs | |||||
| Net Income Before Taxes | 57 | 191 | 119 | 4 | -304 |
| Provision for Income Taxes | |||||
| Net Income After Taxes | 43 | 150 | 92 | 4 | -290 |
| Net Income Before Extraordinary Items | |||||
| Net Income | 43 | 150 | 92 | 4 | -290 |
| Income Available to Common Shareholders Excluding Extraordinary Items | |||||
| Income Available to Common Shareholders Including Extraordinary Items | |||||
| Diluted Net Income | 43 | 150 | 92 | 4 | -290 |
| Diluted Weighted Average Shares | |||||
| Basic EPS Including Extraordinary Items | |||||
| Diluted EPS Including Extraordinary Items | |||||
| Diluted EPS Excluding Extraordinary Items | |||||
| Normalised Income Before Taxes | |||||
| Normalised Income After Taxes | |||||
| Normalised Income Available to Common Shareholders | |||||
| Diluted Normalised EPS | 0.531 | 1.33 | 1.44 | 0.268 | -0.702 |
| Dividends per Share |